YES1 (T348I) in pLX303 Citations (1)

Originally described in: beta-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis.
Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, Schafer EJ, Zack TI, Wang X, Tsherniak A, Schinzel AC, Shao DD, Schumacher SE, Weir BA, Vazquez F, Cowley GS, Root DE, Mesirov JP, Beroukhim R, Kuo CJ, Goessling W, Hahn WC Cell. 2012 Dec 21;151(7):1457-73. doi: 10.1016/j.cell.2012.11.026. Epub 2012 Dec 13. PubMed Journal

---

Articles Citing YES1 (T348I) in pLX303

Articles
Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma. Slemmons KK, Yeung C, Baumgart JT, Juarez JOM, McCalla A, Helman LJ. Cancer Res. 2020 Jul 15;80(14):3046-3056. doi: 10.1158/0008-5472.CAN-19-3853. Epub 2020 Apr 30. PubMed

If you have published an article using this material, please email us at to have your article added to this page.